Medexus Pharma - M&A Summary and Business Overview

Life ScienceCompany

Medexus Pharma M&A Summary

Medexus Pharma has acquired 3 companies, including 1 in the last 5 years.

Medexus Pharma’s largest acquisition to date was in 2018, when it acquired Medac Pharma for $50M. Medexus Pharma has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).

Medexus Pharma Business Overview

Where is Medexus Pharma headquartered?

Medexus Pharma is headquartered in Toronto, Ontario.

What is Medexus Pharma’s revenue?

Medexus Pharma disclosed revenue of 108M USD for 2023 and 77M USD for 2022.

How many employees does Medexus Pharma have?

Medexus Pharma has 98 employees.

What sector is Medexus Pharma in?

Medexus Pharma is a life science company.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2

Medexus Pharma

Medexus Pharmaceuticals, Inc.

10 King Street East, Suite 600,
Toronto, Ontario M5C 1C3
Canada,
(877) 633-3987
www.medexus.com

Medexus Pharma is a pharmaceutical company dedicated to serving the needs of the pediatric community. Pediapharm’s product portfolio includes NYDA®, a breakthrough treatment for head lice; Relaxa™, an osmotic laxative used to treat constipation; EpiCeram®, a non-steroid emulsion for eczema; naproxen suspension, indicated to treat pain and inflammation due to various conditions, including Juvenile Idiopathic Arthritis; Rupall™, an innovative new allergy medication with a unique mode of action; Otixal™, the first and only antibiotic and steroid combination ear drop available in single, sterile, preservative-free and unit-dose packaging; and Cuvposa™, for chronic severe drooling, a condition affecting a significant proportion of cerebral palsy patients. Medexus Pharmaceuticals is headquartered in Toronto, Canada.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 2 1 - - - - 3
vol $67M $30M $97M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Aptevo BioTherapeutics LLC 2020-02-28 30M USD Divestiture
Chicago, Illinois · www.ixinity.com
Medac Pharma, Inc. 2018-10-16 50M USD Divestiture
Chicago, Illinois · www.medacpharma.com
Medexus, Inc. 2018-10-16 17M CAD Add-on Acquisition
Bolton, Ontario · www.medexus.ca
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 97M (100%) - -
Total 3 $97M - -

By Geo

State/Country Buy Value Sell Value
United States 2 80M - -
  Illinois 2 80M - -
Canada 1 17M - -
  Ontario 1 17M - -
Domestic 1 (33%) 17M (18%) - -
Cross-border 2 (67%) 80M (82%) - -
Total 3 $97M - -

Deal Values

buy # Total
< $100M 3 $97M
TOTAL $97M
Largest Medac Pharma, Inc.
$50M (2018-10-16)

M&A Connections

Deals
Acquired from
Strategic(s)
67%
2 (67%)

 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.